Search Results 31-40 of 16593 for immunothérapie Bylaska
Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Stage IV Non-Small Cell Lung Cancer Patients ...
About this study. The primary objectives of this study are to evaluate safety/tolerability and immunogenicity of IMU-201 as monotherapy and in combination ...
Patients with metastatic bladder cancer have few treatment options after failure of chemotherapy until now. In early May, the U.S. Food and Drug Administration ...
Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ...
Cancer treatments, including surgery, radiation, chemotherapy, targeted therapy and immunotherapy, are often combined to cure or control various cancers.
Giving immunotherapy before surgery may be more effective at controlling disease in patients with sarcomatoid mesothelioma than giving immunotherapy alone.
Using a mouse model of the blood cancer multiple myeloma, scientists at Mayo Clinic in Arizona are once again providing insight that could improve care for ...
Rochester, Minn., Scottsdale/Phoenix, Ariz. The purpose of this trial is to compare the usual treatment alone to using immunotherapy (atezolizumab) plus the ...
Cancer is caused by changes (mutations) to genes that control the way cells function. Tumors with high number of mutations may respond well to immunotherapy.
Dr. Dronca's group found that the number of tumor-targeting immune cells in the blood correlated with whether patients with metastatic melanoma, a serious skin ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.